This is in keeping with the close functional relationship between Myc and N-Myc [26, 39] and supports the idea that, as a group, Myc inhibitors may find application in the treatment of neuroblastoma where N-Myc over-expression is highly correlated with disease stage and survival [84]. The gene discussed is MYCN; the disease is neuroblastoma.